Subjects: Economics, Pharmaceutical - Digital Collections - National Library of Medicine Search Results

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NLM Digital Collections

Start Over Subjects Economics, Pharmaceutical

1. Cost savings

Author(s):: Steiner, David J., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 21-December-2020
Subject(s):: Cost Savings
Economics, Pharmaceutical
United States

2. Research and development in the pharmaceutical industry

Author(s):: Austin, David, author
Hayford, Tamara, author
Publication:: [Washington, DC] : Congressional Budget Office, April 2021
Subject(s):: Drug Development -- economics
Drug Industry -- economics
Research -- economics
Economics, Pharmaceutical
United States

3. Equilibrium effects of pharmaceutical bundling: evidence from India

Author(s):: Cao, Shengmao, author
Chatterjee, Chirantan, author
Publication:: [Stanford, CA] : Stanford Institute for Economic Policy Research (SIEPR), January 6, 2022
Subject(s):: Drug Combinations
Drug Costs
Economic Competition
Economics, Pharmaceutical
India
United States

4. Competitive bidding in drug procurement: evidence from China

Author(s):: Cao, Shengmao, author
Yi, Xuejie, author
Yu, Chuan, author
Publication:: [Stanford, CA] : Stanford Institute for Economic Policy Research (SIEPR), January 2022
Subject(s):: Competitive Bidding
Drug Costs
Economics, Pharmaceutical
Models, Economic
China
United States

5. Drug price moderation in Germany: lessons for U.S. reform efforts

Author(s):: Robinson, James C., author
Ex, Patricia, author
Panteli, Dimitra, author
Publication:: [New York, N.Y.] : The Commonwealth Fund, January 2020
Subject(s):: Drug Costs
Economics, Pharmaceutical
Negotiating
Germany
United States

6. Cost savings

Author(s):: Steiner, David J., author
Publication:: [Toronto, Ontario] : Thomson Reuters, 23-December-2019
Subject(s):: Cost Control -- legislation & jurisprudence
Cost Savings
Drug Costs -- legislation & jurisprudence
Economics, Pharmaceutical
Legislation, Drug
United States

7. Drug discount program: status of agency efforts to improve 340B program oversight : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate

Publication:: Washington, DC : United States Government Accountability Office, May 15, 2018
Subject(s):: Drug Costs
Economics, Pharmaceutical
Government Regulation
Medicaid -- economics
United States
United States. Health Resources and Services Administration

8. Drug discount program: federal oversight of compliance at 340B contract pharmacies needs improvement : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, June 2018
Subject(s):: Drug Costs
Economics, Pharmaceutical
Pharmacies -- economics
Contract Services
United States
United States. Health Resources and Services Administration

9. Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, July 11, 2018
Subject(s):: Drug Costs
Economics, Pharmaceutical
Pharmacies -- economics
Contract Services
Government Regulation
United States
United States. Health Resources and Services Administration

10. Medicaid's most costly outpatient drugs

Author(s):: Young, Katherine, author
Rudowitz, Robin, author
Garfield, Rachel, author
Musumeci, MaryBeth, author
Publication:: Menlo Park, CA : Henry J. Kaiser Family Foundation, July 2016
Subject(s):: Drug Costs -- statistics & numerical data
Economics, Pharmaceutical
Medicaid -- economics
Prescription Drugs -- economics
United States